Al Kaller

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Chemokine Receptor Compounds. Top assignees: Anormed, Inc., Genzyme Corporation. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Al Kaller. Retrieved from https://idiyas.com/inventor/al-kaller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 44.4

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 12.9

ph-index = 11

Forward Citations = 274(Granted Patents)

Company Filing History:

Years Active: 2004-2019

Loading Chart...

Areas of Expertise:

Chemokine Receptor

Heterocyclic Compounds

CXCR4

Binding Affinity

Efficacy

Pharmaceuticals

Drug Development

Molecular Design

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10322111 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2019-06-18),

2. 8778967 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2014-07-15),

3. 7863293 - CXCR4 chemokine receptor binding compounds (2011-01-04),

4. 7807694 - Chemokine receptor binding heterocyclic compounds (2010-10-05),

5. 7629337 - Chemokine receptor binding heterocyclic compounds (2009-12-08),

6. 7550484 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2009-06-23),

7. 7396840 - Chemokine receptor binding heterocyclic compounds (2008-07-08),

8. 7354934 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2008-04-08),

9. 7354932 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2008-04-08),

10. 7312234 - Chemokine receptor binding heterocyclic compounds (2007-12-25),

11. 7291631 - CXCR4 chemokine receptor binding compounds (2007-11-06),

12. 7183273 - Chemokine receptor binding heterocyclic compounds (2007-02-27),

13. 7091217 - Chemokine receptor binding heterocyclic compounds (2006-08-15),

14. 7084155 - Chemokine receptor binding heterocyclic compounds (2006-08-01),

15. 6864265 - Chemokine receptor binding heterocyclic compounds (2005-03-08),

Title: Al Kaller: Pioneering Inventor from Vancouver, CA

Introduction: Al Kaller is a distinguished inventor based in Vancouver, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Al Kaller holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative consumer products.

Career Highlights: With a career spanning over two decades, Al Kaller has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions that have garnered international recognition.

Collaborations: Throughout his career, Al Kaller has collaborated with leading universities, research institutions, and industry partners to bring his inventions to life, showcasing his ability to work across disciplines and sectors.

Conclusion: Al Kaller's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, making him a true pioneer in the world of technology and creativity.

Profile summary based on public USPTO records.